TipRanks
Go Ultimate55% OFF

Samit Hirawat Insider Profile

18 Followers

Samit Hirawat, Director at Pacira Pharmaceuticals, holds 6.41K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 83.51K shares in Bristol-Myers Squibb (Ticker: BMY).

Samit Hirawat's Trading History

PCRX
Pacira Pharmaceuticals
Jun 12, 2026DirectorUninformative Buy―$233.08K
BMY
Bristol-Myers Squibb
Apr 29, 2025EVP,Chief Med.Offr.,Drug DevInformative Buy202.22K$5.22M

You May Also Like

Samit Hirawat insider profile FAQ

What is the percentage of profitable transactions made by Samit Hirawat?
The percentage of profitable transactions made by Samit Hirawat is 67%.
What is the average return per transaction made by Samit Hirawat?
The average return per transaction made by Samit Hirawat is 8.40%.
What stocks does Samit Hirawat hold?
Samit Hirawat holds: PCRX, BMY stocks.
What was Samit Hirawat's most profitable transaction?
Samit Hirawat’s most profitable transaction was an Informative Buy of BMY stock on April 29, 2025. The return on the trade was 22.80%.
What is Samit Hirawat's role in Pacira Pharmaceuticals?
Samit Hirawat's role in Pacira Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.